Gerald Balsam
Psychiatry · Orlando, FLNPI 1487729059
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $610 and has fallen 93.5% since, to $39 in 2022.
Across 65 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$136
- Bausch Health US, LLC$133
- Sunovion Pharmaceuticals Inc.$115
- AbbVie$110
- Takeda Pharmaceuticals U.S.A., Inc.$92
- Neos Therapeutics, LP$59
- plus $362 from 14 others
What the payments were for
- Food & beverage$1,008100%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $136 |
| Bausch Health US, LLC | 8 | $133 |
| Sunovion Pharmaceuticals Inc. | 8 | $115 |
| AbbVie(2 entities) | 7 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Neos Therapeutics, LP | 4 | $59 |
| Tris Pharma Inc | 3 | $43 |
| Validus Pharmaceuticals LLC | 2 | $40 |
| Merck | 3 | $38 |
| Lundbeck LLC | 2 | $38 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Adlon Therapeutics L.p. | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Shire North American Group Inc | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Rhodes Pharmaceuticals L.p. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Neuronetics, Inc. | 1 | $9 |
How this compares
$1,009 in reported general payments places this provider in the 60th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Orlando
- Ramon MartinezOrlando$354K
- David MedinaOrlando$199K
- Carlos RuizOrlando$104K
- Morteza NadjafiOrlando$58K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.